Items where Author is "Baliga, R"
 | Up a level |
Group by: Item Type | No Grouping
Jump to: Article | Conference or Workshop Item
Number of items: 6.
Article
Bubb, KJ, Trinder, SL, Baliga, RS, Patel, J, Clapp, LH, MacAllister, RJ and Hobbs, AJ (2014) Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension. Circulation, 130 (6). pp. 496-507.
Baliga, RS, Scotton, CJ, Trinder, SL, Chambers, RC, MacAllister, RJ and Hobbs, AJ (2014) Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis. Br J Pharmacol, 171 (14). pp. 3463-3475.
Derrett-Smith, EC, Dooley, A, Gilbane, AJ, Trinder, SL, Khan, K, Baliga, R, Holmes, AM, Hobbs, AJ, Abraham, D and Denton, CP (2013) Endothelial injury in a transforming growth factor β-dependent mouse model of scleroderma induces pulmonary arterial hypertension. Arthritis Rheum, 65 (11). pp. 2928-2939.
Baliga, RS, Milsom, AB, Ghosh, SM, Trinder, SL, Macallister, RJ, Ahluwalia, A and Hobbs, AJ (2012) Dietary nitrate ameliorates pulmonary hypertension: cytoprotective role for endothelial nitric oxide synthase and xanthine oxidoreductase. Circulation, 125 (23). pp. 2922-2932.
Conference or Workshop Item
Hobbs, A, Bubb, K, Trinder, S, Baliga, R and MacAllister, R (2014) Phosphodiesterase 2 is a novel therapeutic target in pulmonary hypertension In: 17th World Congress of Basic and Clinical Pharmacology, 2014-07-13 - 2014-07-18, Cape Town, South Africa.
Baliga, R, Scotton, C, Trinder, S, Chambers, R, MacAllister, R and Hobbs, A (2011) Protective Role Of Natriuretic Peptides In Pulmonary Fibrosis: A Novel Therapeutic Target? In: American Thoracic Society International Conference, 2011 - ?.